Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

BoNT-B demonstrates significant efficacy in pain associated with cervical dystonia

July 21, 2000

Parecoxib at least equieffective to ketorolac in the relief of dental pain

July 21, 2000

Approval of new treatment for schizophrenia backed by FDA panel

July 21, 2000

Novel series of antioxidants emerges from R&D at ADIR

July 20, 2000

Novel COMT inhibitors for Parkinson's disease under study at Portela

July 20, 2000

Banyu presents new heterocyclic ORL1 receptor antagonists, their preparation and use

July 20, 2000

Centaur completes enrollment in phase IIa Parkinson's disease trial

July 20, 2000

Ro-60-0175 exerts differential effects in combination with antidepressants in mouse model

July 20, 2000

5-HT1A receptor agonist MKC-242 has antiaggressive activity in isolated mice

July 20, 2000

Novel antidepressants with serotonergic mechanisms in the Lundbeck pipeline

July 19, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 16, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Anti-C5aR1 antibodies linked to outcomes in giant cell arteritis
BioWorld Science
More effective glucocorticoid-sparing therapies are needed for the treatment of giant cell arteritis (GCA). Studies found that complement signaling pathways...
Fortvita and Innovent patent new anti-TROP2/B7-H4 ADCs
BioWorld Science
Fortvita Biologics Inc. and Innovent Biologics (Suzhou) Co. Ltd. have jointly reported new antibody-drug conjugates (ADCs) comprising a bispecific antibody or...